Status report
Get it in writing
The official USPTO status record for GMA, serial 76245311, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
GMASerial 76245311 · Principal Register
Dead · Refused
Owner: HiberGen Limited
Class 005 - Pharmaceuticals
Class 042 - Scientific & Technology Services
Filed Apr 24, 2001
The record shows that the GMA application filed by HiberGen Limited, an Irish corporation, was abandoned on August 26 2003 because no Statement of Use or extension was filed after the Notice of Allowance, so the mark is not live or registered. The filing covered Class 005 pharmaceuticals—specifically medical‑research chemicals such as buffers, reagents, fluorescent‑labeled compounds, nucleotides, oligonucleotides and related micro‑ and macro‑arrays for diagnosis, genotyping, mutation detection and drug‑response analysis—and Class 042 scientific‑technology services that include medical diagnosis, clinical‑sample testing, pathogen identification, disease and infection diagnosis, veterinary research, gene‑expression profiling and nucleic‑acid analysis. A similar name used in these scientific or pharmaceutical contexts would raise the closest record‑based concern, while uses outside those fields are farther from the listed scope but not automatically free of risk. The latest meaningful event is the abandonment entry on October 2 2003, and the history contains no oppositions, cancellations or court actions, so no enforcement signals appear. I'd treat this as a meaningful concern if you plan a name in the same biotech or diagnostic space.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.